Protective efficacy of rebamipide for the aspirin induced gastric/small intestinal injury;the clinical trials for volunteers

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: LDA(100mg) and Omeprazole 10mg/day for 2 weeks by oral administration LDA(100mg) and Rebamipide 300mg/day for 2 weeks by oral administration LDA(100mg) and Rebamipide 900mg/day for 2 weeks by oral administration CONDITION: NSAIDs induced small intestinal injury PRIMARY OUTCOME: Evaluation of the small intestinal injuries induced by NSAIDs SECONDARY OUTCOME: Safety INCLUSION CRITERIA: Healthy adults who are 20years or older,and less than 80years of age at the time of obtaining informed consent.
Epistemonikos ID: 03346564b7f744bd99e829ed147d808d94f32133
First added on: Aug 22, 2024